Evommune, Inc. SEC filings EVMN
Evommune, Inc. has 138 filings in SEC EDGAR's recent list, going back to Jan 7, 2025. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| 424B3 | Prospectus | Nov 4, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Oct 15, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 23, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2026 | Sep 15, 2026 |
| 424B3 | Prospectus | Sep 9, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2026 | Sep 8, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 424B3 | Prospectus | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 30, 2026 | Jul 29, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 16, 2026 | — |
| 4 | Insider transaction | Jul 10, 2026 | Jul 8, 2026 |
| 4 | Insider transaction | Jul 8, 2026 | Jul 7, 2026 |
| 424B3 | Prospectus | Jun 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 29, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 144 | Notice of proposed sale | Jun 22, 2026 | — |
| 4 | Insider transaction | Jun 3, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 144 | Notice of proposed sale | Jun 2, 2026 | — |
| 424B3 | Prospectus | Jun 2, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | May 28, 2026 |
| 144 | Notice of proposed sale | Jun 1, 2026 | — |
| 144 | Notice of proposed sale | Jun 1, 2026 | — |
| 144 | Notice of proposed sale | May 28, 2026 | — |
| 144 | Notice of proposed sale | May 28, 2026 | — |
| 424B3 | Prospectus | May 7, 2026 | — |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| EFFECT | Filing | Apr 24, 2026 | — |
| 424B3 | Prospectus | Apr 24, 2026 | — |
| CORRESP | Letter to the SEC | Apr 22, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 22, 2026 | — |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEF 14A | Proxy statement | Apr 21, 2026 | Apr 21, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 16, 2026 |
| S-1 | Registration statement | Apr 17, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 13, 2026 | Apr 13, 2026 |
| S-8 | Employee stock plan registration | Mar 5, 2026 | — |
| 10-K | Annual report | Mar 5, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2026 | Mar 5, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 19, 2026 | — |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 17, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 17, 2026 | — |
| 4 | Insider transaction | Feb 17, 2026 | Feb 17, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 13, 2026 | Feb 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 10, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Dec 22, 2025 | Dec 19, 2025 |
| 4 | Insider transaction | Dec 19, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 11, 2025 | Dec 9, 2025 |
| 10-Q | Quarterly report | Dec 11, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Dec 11, 2025 | Dec 11, 2025 |
| SCHEDULE 13D | Ownership over 5% (active) | Nov 17, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 17, 2025 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Nov 14, 2025 | — |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| S-8 | Employee stock plan registration | Nov 7, 2025 | — |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 7, 2025 | Nov 7, 2025 |
| 424B4 | Prospectus | Nov 6, 2025 | — |
| FWP | Free writing prospectus | Nov 6, 2025 | — |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| 3 | Initial insider ownership | Nov 5, 2025 | Nov 5, 2025 |
| CERT | Nyse certification | Nov 5, 2025 | — |
| 8-A12B | Filing | Nov 4, 2025 | — |
| FWP | Free writing prospectus | Oct 30, 2025 | — |
| S-1/A | Amended registration statement | Oct 17, 2025 | — |
| S-1 | Registration statement | Oct 9, 2025 | — |
| DRS/A | Filing | Sep 23, 2025 | — |
| DRSLTR | Filing | Sep 22, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2025 | — |
| DRS/A | Filing | Sep 2, 2025 | — |
| DRSLTR | Filing | Aug 29, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2025 | — |
| DRSLTR | Filing | Jul 18, 2025 | — |
| DRS/A | Filing | Jul 18, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 10, 2025 | — |
| DRS | Filing | May 14, 2025 | — |
| D | Filing | Jan 8, 2025 | — |
| D | Filing | Jan 8, 2025 | — |
| D | Filing | Jan 8, 2025 | — |
| D | Filing | Jan 7, 2025 | — |
Showing 138 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- EVMN (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Palo Alto, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2044725
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.